• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Lower vulvar cancer-related mortality in African Americans

bys25qthea
July 27, 2013
in Chronic Disease, Obstetrics, Public Health
Reading Time: 2 mins read
Share on FacebookShare on TwitterShare on LinkedIn

Image: PD

1. African American women were more likely to present with vulvar cancer at a younger age compared to white women.

2. Among women ≥ 60 years of age, African Americans had lower vulvar cancer related mortality. 

Evidence Rating Level: 2 (Good)

Study Rundown: This study explored the epidemiology of vulvar cancer and found that compared to white women, African Americans were more likely to be younger and have more advanced disease upon diagnosis, yet experienced lower rates of vulvar cancer related mortality compared to white women. Prior cross-sectional and retrospective cohort studies have failed to identify racial differences in mortality rate.

Strengths of this study include a large sample size, detailed data on cancer-related variables and long-term follow-up. Limitations include a retrospective design and variations in treatment standards between providers and facilities. Future studies might evaluate trends in mortality over time and assess differences in  vulvar cancer related mortality by HPV status.

RELATED REPORTS

AI-drafted responses to patient messages linked to faster reply times but no drop in after-hours work for clinicians

A community health initiative in low-income areas may reduce hospital admission rates

Click to read the study in the American Journal of Obstetrics & Gynecology

Relevant Reading: Impact of race and ethnicity on treatment and survival of women with vulvar cancer in the United States

In-Depth [retrospective cohort study]: This study analyzed data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) registry to evaluate differences in mortality trends of 7,363 white and 610 African American (AA) women who were diagnosed with histology-confirmed vulvar cancer between 1973 and 2009.

Mean age of diagnosis was 57 years for AA and 67 years for whites. AA women were more likely to have regional (26.7% vs 24.6%) and distant metastasis (5.6% vs. 3.6%) compared with white women and were less likely to have well-differentiated cancer (15.9% vs. 21.1%). AA women were less likely to be treated with surgery alone (70.2% vs. 76.1%) and more likely to receive radiotherapy or combination therapy. Overall, AA women ≥ 60 years had lower hazards of vulvar cancer related mortality in 1990-1999 and 2000-2009 (HR 0.39, CI 0.22-0.70).

By Denise Pong, MPH and Leah Hawkins, MD, MPH

More from this author: Active phase of labor longer in twin deliveries, Perioperative protocol shortens stay after major gynecologic surgery, Severe endometriosis associated with poor IVF outcomes, New guidelines for intrapartum management of patients with mental disorders, Oral glucose tolerance test preferred for pre-diabetes screening in PCOS

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: gynecologyhealthvulvar cancer
Previous Post

Breast cancer mutations linked with nodal metastases

Next Post

The MIRACL trial: Atorvastatin reduces recurrent ischemia post-ACS [Classics Series]

RelatedReports

Clinical AI collage: a thoughtful clinician in a white coat beside a network of blue dots, a closed blank folder and a ribbon
All Specialties

AI-drafted responses to patient messages linked to faster reply times but no drop in after-hours work for clinicians

November 3, 2026
An artistic representation featuring a door with a key, symbolizing access or opportunity, alongside images of buildings and a heartbeat line, suggesting themes of health and housing.
Chronic Disease

A community health initiative in low-income areas may reduce hospital admission rates

October 20, 2026
An illustration showcasing knee anatomy, rehabilitation exercises with a resistance band, and surgical instruments on a tray, emphasizing meniscus therapy and surgery.
Orthopedic Surgery

Preoperative self-preparation for total knee arthroplasty is multifactorial and can be optimized by targeting external support and internal motivation

October 17, 2026
A young boy studying at a desk with books and a contrasting image of an adult man walking outdoors, symbolizing the life course from childhood to adulthood.
Pediatrics

Children with intellectual and developmental disabilities have increased risks of depression and anxiety

October 14, 2026
Next Post
Classics Series, Landmark Trials in Medicine

The MIRACL trial: Atorvastatin reduces recurrent ischemia post-ACS [Classics Series]

2 Minute Medicine Rewind July 22 – July 28, 2013

Sublingual immunotherapy may be safe and effective for asthma and allergic rhinoconjunctivitis

Asthma remission common by late adolescence

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Medicaid status, race and ethnicity are independently associated with increased odds of severe maternal morbidity
  • Artificial intelligence-generated pre-visit summaries improved communication outcomes in neurosurgical consultations
  • Midline catheters may reduce catheter-related bloodstream infections compared with peripherally inserted central catheters in intensive care unit patients
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • Physician Pay by Specialty
    • ICD-10 Code Lookup
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.